Characterization of the Angiotensin II Receptor Antagonist TCV-116 in Healthy Volunteers
Authors:
- 1 January 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 25 (1) , 14-21
Abstract
The purpose of this study was to assess the inhibitory effect of TCV-116, an orally active angiotensin II (Ang II) antagonist, on the pressor action of exogenous Ang II and to determine the compensatory rise in plasma renin activity and Ang II levels. Twenty-three male volunteers were treated for 8 days in a double-blind fashion with either placebo or TCV-116 (1, 2, or 4 mg PO daily) and challenged on the first, fourth, and eighth days with repeated bolus injections of Ang II. An additional 4 subjects received 8 mg PO daily in a single-blind fashion. The inhibitory effect on the systolic blood pressure response to Ang II was long lasting and clearly dose related. Six hours after 4 mg TCV-116, the systolic blood pressure response to a given dose of Ang II was reduced to 40±4% and 35±8% of baseline value on days 1 and 8, respectively. TCV-116 induced a dose-related increase in plasma renin activity and Ang II levels that was more pronounced on the eighth than on the first day of drug administration. Despite this compensatory mechanism, the relation between the time-integrated systolic blood pressure response to Ang II and the time-integrated CV-11974 levels, the active metabolite of TCV-116, was not different between days 1 and 8. In conclusion, TCV-116 appears to be a well-tolerated, orally active, potent, and long-lasting antagonist of Ang II in men.Keywords
This publication has 32 references indexed in Scilit:
- Noninvasive Blood Pressure Monitoring at the Finger for Studying Short Lasting Pressor Responses in ManThe Journal of Clinical Pharmacology, 1990
- Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.Hypertension, 1990
- Caffeine-Induced Diuresis and Atrial Natriuretic PeptidesJournal of Cardiovascular Pharmacology, 1990
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing.Hypertension, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Evaluation of the Penàz servo-plethysmo-manometer for the continuous, non-invasive measurement of finger blood pressureBasic Research in Cardiology, 1984
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973